Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma:: German and Austrian experience

被引:126
作者
Dralle, H
Gimm, O
Simon, D
Frank-Raue, K
Görtz, G
Niederle, B
Wahl, RA
Koch, B
Walgenbach, S
Hampel, R
Ritter, MM
Spelsberg, F
Heiss, A
Hinze, R
Höppner, W
机构
[1] Martin Luther Universitat Halle Wittenberg, Klin Allegmeinchirurg, D-06097 Halle, Germany
[2] Heinrich Heine Univ, Klin Allgemeine & Unfallchirurg, D-40225 Dusseldorf, Germany
[3] Gemeinschaftspraxis Innere Med Endokrinol, D-69120 Heidelberg, Germany
[4] St Marien Hosp, D-44534 Lunen, Germany
[5] Univ Klin Vienna, Klin Abt Allgemeinchirurg, A-1090 Vienna, Austria
[6] Burgerhosp Frankfurt Am Main, Chirurg Klin, D-60318 Frankfurt, Germany
[7] Westpfalz Klinikum GMBH, Chirurg Klin 1, D-67655 Kaiserslautern, Germany
[8] Univ Rostock, Klin & Poliklin Innere Med, D-18055 Rostock, Germany
[9] Johannes Gutenberg Universitat Mainz, Allgemein & Abdominalchirurg Klin & Poliklin, D-55101 Mainz, Germany
[10] Univ Munich, Klinikum Grosshadern, Med Klin & Poliklin 2, D-81377 Munich, Germany
[11] Krankenhaus Martha Maria, Chirurg Abt, D-81479 Munich, Germany
[12] Zent Klinikum Augsburg, Klin Allgemein & Visceralchirurg, D-86009 Augsburg, Germany
[13] Martin Luther Universitat Halle Wittenberg, Inst Pathol, D-06097 Halle, Germany
[14] Inst Hormon & Fortpflanzungsforsch, D-22529 Hamburg, Germany
关键词
D O I
10.1007/s002689900463
中图分类号
R61 [外科手术学];
学科分类号
摘要
When mutations of the RET proto-oncogene were found in 1993 to account for hereditary medullary thyroid carcinoma (MTC), surgeons obtained the opportunity to operate on patients prophylactically (i.e., at a clinically asymptomatic stage). Whether this approach is justified, and, if so, when and to which extent surgery should be performed remained to be clarified. A questionnaire was sent to all surgical departments in Germany and Austria. All of the patients who fulfilled the following criteria were enrolled: (1) preoperatively proved RET mutation; (2) age less than or equal to 20 years, (3) clinically asymptomatic thyroid C cell disease; and (4) TNM classification pTO-1/pNX/pNO-1/MO. Seventy-five patients mere identified, and fifteen mutations were detected in six codons. Two adolescents had unilateral pheochromocytomas as part of the multiple endocrine neoplasia II (MEN-PI) syndrome. No hyperparathyroidism was noted. All patients underwent total thyroidectomy, and 57 patients went on to have lymph node dissection. Parathyroid glands were removed in 34 patients and autografted in 11. Histopathology revealed MTC in 46 patients (61%, youngest 4 years); C cell hyperplasia (CCH) only was detected in the other 29 patients. Three patients had lymph node metastases (LNMs) the youngest being age 14 Sears. Calcitonin levels were not useful for differentiating between CCH and MTC, but in all patients with LNMs at least the stimulated calcitonin levels mere assayed. After surgery, five patients (6.7%) sustained permanent hypoparathyroidism, and one patient (1.3%) had a permanent unilateral recurrent nerve palsy. All but three patients (96%) were biochemically cured. In conclusion, prophylactic total thyroidectomy can be performed safely in experienced centers. We recommend prophylactic total thyroidectomy at age 6. Cervicocentral lymph node dissection should be included when calcitonin levels are elevated or if patients are older than 10 years. Bilateral lymph node dissection should be performed if LNMs are suspected or when patients with elevated calcitonin are older than 85 years.
引用
收藏
页码:744 / 751
页数:8
相关论文
共 28 条
[1]   C-CELL HYPERPLASIA IN THYROID-TISSUE ADJACENT TO FOLLICULAR CELL TUMORS [J].
ALBORESSAAVEDRA, J ;
MONFORTE, H ;
NADJI, M ;
MORALES, AR .
HUMAN PATHOLOGY, 1988, 19 (07) :795-799
[2]   Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: Is parathyroid transplantation indicated? [J].
Decker, RA ;
Geiger, JD ;
Cox, CE ;
Mackovjak, M ;
Sarkar, M ;
Peacock, ML .
WORLD JOURNAL OF SURGERY, 1996, 20 (07) :814-821
[3]  
DELELLIS RA, 1993, TUMOS PARATHYROID GL, P65
[4]   MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].
DONISKELLER, H ;
DOU, SS ;
CHI, D ;
CARLSON, KM ;
TOSHIMA, K ;
LAIRMORE, TC ;
HOWE, JR ;
MOLEY, JF ;
GOODFELLOW, P ;
WELLS, SA .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856
[5]  
Dralle H, 1992, Recent Results Cancer Res, V125, P167
[6]  
DRALLE H, 1996, DTSCH ARZTEBL, V93, pA899
[7]   The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].
Eng, C ;
Clayton, D ;
Schuffenecker, I ;
Lenoir, G ;
Cote, G ;
Gagel, RF ;
vanAmstel, HKP ;
Lips, CJM ;
Nishisho, I ;
Takai, SI ;
Marsh, DJ ;
Robinson, BG ;
FrankRaue, K ;
Raue, F ;
Xue, FY ;
Noll, WW ;
Romei, C ;
Pacini, F ;
Fink, M ;
Niederle, B ;
Zedenius, J ;
Nordenskjold, M ;
Komminoth, P ;
Hendy, GN ;
Gharib, H ;
Thibodeau, SN ;
Lacroix, A ;
Frilling, A ;
Ponder, BAJ ;
Mulligan, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579
[8]   Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype [J].
FrankRaue, K ;
Hoppner, W ;
Frilling, A ;
Kotzerke, J ;
Dralle, H ;
Haase, R ;
Mann, K ;
Seif, F ;
Kirchner, R ;
Rendl, J ;
Deckart, HF ;
Ritter, MM ;
Hampel, R ;
Klempa, J ;
Scholz, GH ;
Raue, F ;
Bogner, U ;
Brabant, G ;
Grussendorf, M ;
Hartenstein, CH ;
Heidemann, P ;
Hensen, J ;
Dorr, AG ;
Hohne, T ;
HornigFranz, I ;
Hufner, M ;
Kress, I ;
Langer, HJ ;
Lottermoser, K ;
Schweikert, HU ;
Kusterer, K ;
Menken, U ;
Mercier, J ;
Oelkers, W ;
Ziegler, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1780-1783
[9]   Application of genetic screening in families with hereditary medullary thyroid carcinoma [J].
FrankRaue, K ;
Hoppner, W ;
Buhr, H ;
Herfarth, C ;
Ziegler, R ;
Raue, F .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :108-110
[10]   PROVOCATIVE TESTING FOR OCCULT MEDULLARY CARCINOMA OF THE THYROID - FINDINGS IN 7 CHILDREN WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-IIA [J].
GRAHAM, SM ;
GENEL, M ;
TOULOUKIAN, RJ ;
BARWICK, KW ;
GERTNER, JM ;
TORONY, C .
JOURNAL OF PEDIATRIC SURGERY, 1987, 22 (06) :501-503